密度	1.23±0.1 g/cm3 (20 ºC

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Degradation kinetics of metronidazole and olsalazine by bacteria in ascending colon and in feces of healthy adults.Maria Vertzoni et al.International journal of pharmaceutics, 413(1-2), 81-86 (2011-05-05) Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.K W Schroeder Scandinavian journal of gastroenterology. Supplement, (236)(236), 42-47 (2002-11-01) Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.David T Rubin et al.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 4(11), 1346-1350 (2006-10-25) Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.William J Sandborn Reviews in gastroenterological disorders, 6(2), 97-105 (2006-05-16) Inhibition of human thiopurine S-methyltransferase by various nonsteroidal anti-inflammatory drugs in vitro: a mechanism for possible drug interactions.Kersti Oselin et al.Drug metabolism and disposition: the biological fate of chemicals, 35(9), 1452-1454 (2007-06-08) [Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates].Lutz Buschhausen et al.Medizinische Klinik (Munich, Germany : 1983), 101(10), 791-795 (2006-10-14) Molecular nanofibers of olsalazine form supramolecular hydrogels for reductive release of an anti-inflammatory agent.Xinming Li et al.Journal of the American Chemical Society, 132(50), 17707-17709 (2010-12-03) Different therapy for different types of ulcerative colitis in China.Xue-Liang Jiang et al.World journal of gastroenterology, 10(10), 1513-1520 (2004-05-11) Study of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses.U Knoll et al.Journal of veterinary pharmacology and therapeutics, 25(2), 135-143 (2002-05-10) Thrombocytopenia associated with 5-aminosalicylate prodrug, olsalazine: is the devil still there?Yuefeng Rao et al.International journal of clinical pharmacy, 35(4), 529-531 (2013-04-30) Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.Holger Sann et al.Life sciences, 92(12), 708-718 (2013-02-13) Treating TNBS-induced colitis in rats with probiotics.Yue-Meng Wan et al.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 22(5), 486-493 (2012-01-12) Comparison of the electrochemical properties of some colon-specific prodrugs of mesalazine.B Nigović et al.Die Pharmazie, 57(7), 468-470 (2002-08-10) Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.M V Singer et al.Hepato-gastroenterology, 53(69), 317-321 (2006-06-27) When less is not more but at least equivalent.Stephen Holland Inflammatory bowel diseases, 10(6), 890-891 (2005-01-01) Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.Keri A Kles et al.Inflammatory bowel diseases, 11(3), 253-257 (2005-03-01) Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.Lynn W Maines et al.Inflammopharmacology, 18(2), 73-85 (2010-02-13) High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.T-M-H Nguyen et al.International journal of clinical pharmacology and therapeutics, 48(4), 275-281 (2010-04-01) The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.Danial E Baker et al.Reviews in gastroenterological disorders, 4(2), 86-91 (2004-06-10) [Oral therapy instead of enemas]. MMW Fortschritte der Medizin, 145(8), 56-56 (2003-03-29) The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.Laurie M Edmond et al.Inflammatory bowel diseases, 9(1), 10-17 (2003-03-27) A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.Gerassimos J Mantzaris et al.The American journal of gastroenterology, 99(6), 1122-1128 (2004-06-08) The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.Florian Loher et al.The Journal of pharmacology and experimental therapeutics, 305(2), 549-556 (2003-02-28) New pH-sensitive glycopolymers for colon-specific drug delivery.M Mahkam Drug delivery, 14(3), 147-153 (2007-04-25) Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.E V Loftus et al.Alimentary pharmacology & therapeutics, 19(2), 179-189 (2004-01-16)

备注